Vissing J

References (3)

Title : Comorbidities and Treatment Patterns in People With Myasthenia Gravis in Denmark, Finland and Sweden: A Population-Based Observational Study - Atula_2026_Muscle.Nerve__
Author(s) : Atula S , Piehl F , Schager I , Berggren F , Humle K , Savolainen M , Pitsi D , Mehtala J , Vesikansa A , Vaananen RM , Ylisaukko-oja T , Vissing J
Ref : Muscle & Nerve , : , 2026
Abstract :
PubMedSearch : Atula_2026_Muscle.Nerve__
PubMedID: 41834075

Title : Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment - Gilhus_2024_Eur.J.Neurol__e16229
Author(s) : Gilhus NE , Andersen H , Andersen LK , Boldingh M , Laakso S , Leopoldsdottir MO , Madsen S , Piehl F , Popperud TH , Punga AR , Schirakow L , Vissing J
Ref : Eur Journal of Neurology , :e16229 , 2024
Abstract :
PubMedSearch : Gilhus_2024_Eur.J.Neurol__e16229
PubMedID: 38321574

Title : Pharmacologic treatment of downstream of tyrosine kinase 7 congenital myasthenic syndrome - Witting_2014_JAMA.Neurol_71_350
Author(s) : Witting N , Vissing J
Ref : JAMA Neurol , 71 :350 , 2014
Abstract :
PubMedSearch : Witting_2014_JAMA.Neurol_71_350
PubMedID: 24425145